Linden Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Linden Advisors’s Portfolio TDAC Stock Details TDAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3M	Buy	1,150,000 +550,000	+92%	+$5.87M	0.06%	175
2026 Q1	$6.34M	Hold	600,000	–	–	0.04%	253
2025 Q4	$6.29M	Hold	600,000	–	–	0.04%	226
2025 Q3	$6.21M	Hold	600,000	–	–	0.04%	201
2025 Q2	$6.18M	Hold	600,000	–	–	0.04%	206
2025 Q1	$6.05M	Buy	+600,000	New	+$6.03M	0.04%	180

Other funds holding TDAC

Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Linden Advisors's TDAC Position: Q2 2026 in Review

Linden Advisors increased its Translational Development Acquisition Corp (TDAC) stake by 92% in Q2 2026, buying an estimated $5.87M and bringing the position to 1,150,000 shares worth $12.3M. The position accounts for 0.06% of the portfolio, ranked #175.

Linden Advisors first reported a position in TDAC in Q1 2025 and has held it in 6 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

Linden Advisors held 1,150,000 shares of Translational Development Acquisition Corp worth $12.3M as of Q2 2026.
Linden Advisors bought 550,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $5.87M.
Translational Development Acquisition Corp made up 0.06% of Linden Advisors's portfolio in Q2 2026, its #175 holding.
Linden Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 6 quarters since.
35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Linden Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.